The primary RNA transcript of the calcitonin-(CT) gene is processed by a unique splicing mechanism called """"""""alternative splicing"""""""" to produce a messenger RNA (mRNA) coding for calcitonin or a mRNA coding for a newly described protein called calcitonin gene-related peptide (CGRP). We have demonstrated production of both of these mRNA species by the TT cells, a human medullary thyroid carcinoma cell line and have demonstrated an effect of glucocorticoids on the alternate splicing process resulting in an increase in the production of CT mRNA and a decrease in the production of CGRP mRNA. In an attempt to further understand the alternate splicing process and how it is regulated by glucocorticoids, an in vitro splicing system will be established utilizing a human genomic clone for the CT gene. Specific sequences of importance in the alter- native splicing process will be cloned into an SP6 or other transcription vector. Newly synthesized RNA from these transcription vectors will be used as substrate for an in vitro splicing assay. Questions to be asked with this system include: 1. Will nuclear extracts from glucocorticoid-treated cells splice CT RNA differently than extracts from control cells? 2. Will alteration of splice site sequences or polyadenylation site sequences change the alternative splicing process? 3. Can the specific sequences shown to affect the splicing process be used as a probe to isolate and purify factors important in the regulation of splicing? If efforts to develop an in vitro splicing system are unsuccessful, a transient transfection system to study RNA processing in intact cells will be developed. The questions to be asked in the transfection model are similar to those which could be asked in the in vitro splicing system, although it may be more difficult to use the system to purify potential splicing factors. There are now over 40 examples of genes whose RNA undergoes alternative splicing. An understanding of the splicing mechanism and how it is regulated will provide information of fundamental importance for the control of the growing number of genes processed by alternative splicing.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK038146-02
Application #
3237377
Study Section
Endocrinology Study Section (END)
Project Start
1988-09-20
Project End
1991-02-28
Budget Start
1989-09-01
Budget End
1991-02-28
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Lou, H; Gagel, R F (2001) Alternative ribonucleic acid processing in endocrine systems. Endocr Rev 22:205-25
Hoff, A O; Cote, G J; Fritsche Jr, H A et al. (1999) Calcium-induced activation of a mutant G-protein-coupled receptor causes in vitro transformation of NIH/3T3 cells. Neoplasia 1:485-91
Lou, H; Helfman, D M; Gagel, R F et al. (1999) Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3'-terminal exon. Mol Cell Biol 19:78-85
Lou, H; Gagel, R F (1998) Alternative RNA processing--its role in regulating expression of calcitonin/calcitonin gene-related peptide. J Endocrinol 156:401-5
Lou, H; Neugebauer, K M; Gagel, R F et al. (1998) Regulation of alternative polyadenylation by U1 snRNPs and SRp20. Mol Cell Biol 18:4977-85
Thomas, P M; Wohllk, N; Huang, E et al. (1996) Inactivation of the first nucleotide-binding fold of the sulfonylurea receptor, and familial persistent hyperinsulinemic hypoglycemia of infancy. Am J Hum Genet 59:510-8
Wohllk, N; Cote, G J; Bugalho, M M et al. (1996) Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 81:3740-5
Lou, H; Gagel, R F; Berget, S M (1996) An intron enhancer recognized by splicing factors activates polyadenylation. Genes Dev 10:208-19
Lou, H; Yang, Y; Cote, G J et al. (1995) An intron enhancer containing a 5' splice site sequence in the human calcitonin/calcitonin gene-related peptide gene. Mol Cell Biol 15:7135-42
Thomas, P M; Cote, G J; Wohllk, N et al. (1995) Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 268:426-9

Showing the most recent 10 out of 20 publications